West Pharmaceutical Services Inc
(BSP:W2ST34)
R$
55.16
0.16 (0.29%)
Market Cap: 139.83 Bil
Enterprise Value: 138.71 Bil
PE Ratio: 48.32
PB Ratio: 8.58
GF Score: 89/100 West Pharmaceutical Services Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 14, 2023 / 09:50AM GMT
Release Date Price:
R$48.85
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst for Bank of America. Welcome to our 2023 Global Healthcare Conference. Our next company presenting today is West Pharmaceutical Services. With us today from West are CFO, Bernard Birkett; and IR Quintin Lai. Gentlemen, welcome. Thanks for making the trip over from Pennsylvania. I appreciate it.
Bernard J. Birkett
West Pharmaceutical Services, Inc. - Senior VP and Chief Financial & Operations Officer
Thank you. And thank you for the invite. It's good to be here.
Questions & Answers
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
Our pleasure. So a lot going on. So I'm not going to ask a question on GLPs at all. So because nobody is interested in that. So we'll just skip that. Do you want to sort of do opening comments in terms of where we are, in terms of like you just exited second quarter, strong demands across the business,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot